Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer

Clinical Cancer Research

Volumn 5, Issue 4, 1999, Pages 933-936

  Hiraki, Akio ^a   Kaneshige, Toshihiko ^b   Kiura, Katsuyuki ^a   Ueoka, Hiroshi ^a   Yamane, Hiromichi ^a   Tanaka, Motoyuki ^a   Harada, Mine ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LUNG CANCER; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ESCAPE;

CARCINOMA, NON-SMALL-CELL LUNG; DNA; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNOLOGIC SURVEILLANCE; LUNG NEOPLASMS; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; SEROTYPING; TUMOR CELLS, CULTURED;

EID: 0032958294     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Garrido, F., and Ruiz-Cabello, F. MHC expression on human tumors: its relevance for local tumor growth and metastasis. Semin. Cancer Biol., 2: 3-10, 1991.
2. Ruiz-Cabello, F., Klein, E., and Garrido, F. MHC antigens on human tumors. Immunol. Lett., 29: 181-189, 1991.
3. Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., and Stern, P. L. Natural history of HLA expression during tumour development. Immunol. Today, 14: 491-499, 1993.
4. Ferrone, S., and Marincola, F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16: 487-494, 1995.
5. Garrido, F., Ruiz-Cabello, F., Cabrera, T., Perez-Villar, J. J., Lopez-Botet, M., Duggan-Keen, M., and Stern, P. L. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today, 18: 89-95, 1997.
6. Grilli, R., Oxman, A. D., and Julian, J. A. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J. Clin. Oncol., 11: 1866-1872, 1993.
7. Moribe, T., Kaneshige, T., and Inoko, H. Complete HLA-A DNA typing using the PCR-RFLP method combined with allele group- and sequence-specific amplification. Tissue Antigens, 50: 535-545, 1997.
8. Yoshida, M., Kimura, A., Numano, F., and Sasazuki, T. Polymerasechain-reaction-based analysis of polymorphism n the HLA-B gene. Hum. Immunol., 34: 257-266, 1992.
9. Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J., and Welsh, K. I. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens, 46: 355-367, 1995.
10. Moribe, T., Kaneshige, T., Hirakata, M., Mimori, T., Akitsuki, M., and Inoko, H. Identification of a DR B1 *0405 variant (DRB1 *04052) using the PCR-RFLP method. Tissue Antigens, 47: 450-453, 1996.
11. Saito, S., Ota, S., Hashizume, K., Yamada, E., Kaneshige, T., Kinoshita, T., Hashimoto, M., Oguchi, H., Ishii, E., and Fukushima, H. A new HLA-DQB1 *0306 allele sharing motifs from DQB1 *03032 and DQB 1 *04 sequences. Tissue Antigens, 48: 580-585, 1996.
12. Kaneshige, T., Hashimoto, M., Matsumoto, Y., Kinoshita, T., Hirasawa, T., Uchida, K., and Inoko, H. Serologic and nucleotide sequencing analyses of a novel DR52-associated DRB1 allele with the DR 'NJ25′ specificity, designated DRB1 * 1307. Hum. Immunol., 41: 151-159, 1994.
13. Terasaki, P. I., and McClelland, J. D. Microdroplet assay of human serum cytotoxins. Nature (Lond.), 204: 998-1000, 1964.
14. Momburg, F., Ziegler, A., Harpprecht, J., Moller, P., Moldenhauer, G., and Hammerling, G. J. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J. Immunol., 142: 352-358, 1989.
15. Lopez-Nevot, M. A., Esteban, F., Ferron, A., Gutierrez, J., Oliva, M. R., Romero, C., Huelin, C., Ruiz-Cabello, F., and Garrido, F. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br. J. Cancer, 59: 221-226, 1989.
16. Andersson, M. L., Stam, N. J., Klein, G., Ploegh, H. L., and Masucci, M. G. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. Int. J. Cancer, 47: 544-550, 1991.
17. Versteeg, R., Kruse-Wolters, K. M., Plomp, A. C., van Leeuwen, A., Stam, N. J., Ploegh, H. L., Ruiter, D. J., and Schrier, P. I. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J. Exp. Med., 170: 621-635, 1989.
18. Blanchet, O., Bourge, J. F., Zinszner, H., Tatari. Z., Degos, L., and Paul, P. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. Int. J. Cancer Suppl., 6: 138-145, 1991.
19. Soong, T. W., Oei, A. A., and Hui, K. M. Regulation of HLA class I gene expression in human colorectal carcinoma. Semin. Cancer Biol., 2: 23-33, 1991.
20. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A., and Bennink, J. R. Identification of human cancers deficient in antigen processing. J. Exp. Med., 177: 265-272, 1993.
21. Gattoni-Celli, S., Kirsch, K., Timpane, R., and Isselbacher, K. J. β2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface. Cancer Res., 52: 1201-1204, 1992.
22. van't Veer, L. J., Beijersbergen, R. L., and Bernards, R. N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-κB. EMBO J., 12: 195-200, 1993.
23. Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yannelli, J., Mixon, A., Restifo, N. P., Herlyn, M., and Rosenberg, S. A. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153: 1225-1237, 1994.
24. Torres, M. J., Ruiz-Cabello, F., Skoudy, A., Berrozpe, G., Jimenez, P., Serrano, A., Real, F. X., and Garrido, F. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens, 47: 372-381, 1996.